source Post navigation GLP-1 receptor agonists’ impact on cardio-renal outcomes and mortality in T2D with acute kidney disease – Nature.com New Research Explores Exercise Solutions for Type 2 Diabetics Living with Long COVID – Hunter Medical Research Institute